HPBCD was tested as a possible therapeutic agent in Amyotrophic Lateral Sclerosis (ALS) model
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), is a rare and terminal neurodegenerative disease that results
A forum for researchers, students and applicants in the field of cyclodextrin technology
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), is a rare and terminal neurodegenerative disease that results